NXTCL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NextCell Pharma AB

Watchlist Manager

Watchlist

Price: 1.078 SEK -1.82%

Market Cap: kr136.2m

N	NextCell Pharma AB STO:NXTCL	SE
C	China Satellite Communications Co Ltd SSE:601698	CN
	MMG Ltd HKEX:1208	AU
	Pebblebrook Hotel Trust NYSE:PEB	US
	Bayerische Motoren Werke AG F:BMW3	DE
G	Goldman Sachs BDC Inc F:GSB	US
	Emerson Electric Co NYSE:EMR	US
R	Revo Insurance SpA MIL:REVO	IT
	CarGurus Inc NASDAQ:CARG	US
	Kronos Worldwide Inc NYSE:KRO	US
	Premium Group Co Ltd TSE:7199	JP
N	Nexon Co Ltd TSE:3659	JP
E	EnerSys XBER:FDN	US
	Societe de Services de Participations, de Direction et d'Elaboration SA LSE:0OH1	BE
E	ESCO Technologies Inc SWB:ET7	US

Profitability Summary

NextCell Pharma AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-187%

Negative 3Y Average Gross Margin

-174%

Declining Gross Margin

-25% > -187%

Negative Operating Margin

-378%

Negative 3Y Average Operating Margin

-383%

Operating Margin is Increasing

-471% > -378%

Negative Net Margin

-372%

Negative 3Y Average Net Margin

-374%

Net Margin is Increasing

-461% > -372%

Negative Free Cash Flow Margin

-408%

Negative 3Y Average Free Cash Flow Margin

-409%

Free Cash Flow Margin is Increasing

-515% > -408%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-127%

ROIC is Increasing

-154% > -153%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.